Business Description
BioVersys AG is a Swiss biotech company focused on creating new medicines to fight dangerous bacterial infections that are increasingly resistant to existing treatments. Its most advanced drug candidates target life-threatening conditions such as drug-resistant pneumonia, tuberculosis, and bloodstream infections. Founded in 2008 and headquartered in Basel, the company works alongside partners like Shionogi & Co. to advance its pipeline from early research through clinical trials.
